Health & Biotech
Pharmaxis (ASX: PXS) has changed its name to Syntara - SNT (ASX: SNT).
Below are the previous articles from Pharmaxis (ASX: PXS):
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX trips at starting gun while US Futures jump on world not ending yet
Health & Biotech
Move over Neuren – Bioshares reckons these ASX health stocks could pop with upcoming key catalysts
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but don’t throw the baby out with the bathwater
Health & Biotech
ASX Health Stocks: Cannabis stock Little Green Pharma awarded French trial tender for CBD50
Health & Biotech
ASX biotechs are looking up, and the FDA breakthroughs are starting to flow
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall as investors fail to reward good news
Health & Biotech
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight
News
CLOSING BELL: A crazy ride for tech stocks and Wildcat as the ASX dips 0.22%
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Brokers see blue sky for these 3 ASX biotech stocks, with massive price targets
Health & Biotech
ASX Health Stocks: Pharmaxis and Aroa lift on FDA news, Cynata to commence Phase 2 trial
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall, Healius receives $1.52 billion takeover offer
News
Trading Places: Rinehart makes play for Warrego Energy, Whitehaven gets new substantial shareholder
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rattling the tin, Telix shares soar ~26% on positive quarterly results
Health & Biotech
Clinical Trials 101: How to spot a clinical trial with a strong chance of getting a drug to market
Health & Biotech
